Jennifer Lai
Transplant Hepatology · San Francisco, CANPI 1649397241
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $54,289 of the $70,314 with a category attached, or 77.2%. Novo Nordisk accounts for 73.2% of it on its own, with 8 other manufacturers making up the rest. Among transplant hepatology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 43 payments — averaging $1635.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$51K
- Boehringer Ingelheim International GmbH$15K
- Nestle Healthcare Nutrition Inc.$3K
- Biomarin Pharmaceutical Inc.$750
- Sanofi-aventis U.S. LLC$147
- Madrigal Pharmaceuticals$102
- plus $211 from 3 others
Across 30 payments — averaging $6390.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novavax Inc$103K
- Gilead$89K
What the payments were for
- Consulting fees$54,28977%
- Speaking & faculty fees$7501%
- Travel & lodging$14,03020%
- Food & beverage$1,1462%
- Education$990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 21 | $51,450 |
| Boehringer Ingelheim International GmbH | 11 | $14,929 |
| Nestle Healthcare Nutrition Inc. | 4 | $2,723 |
| Biomarin Pharmaceutical Inc. | 1 | $750 |
| Sanofi-aventis U.S. LLC | 1 | $147 |
| Madrigal Pharmaceuticals | 1 | $102 |
| Johnson & Johnson | 1 | $99 |
| Salvin Dental Specialties, Inc. | 2 | $91 |
| Novartis | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- THYMOGLOBULIN$147
- REZDIFFRA$102
How this compares
$70,314 in reported general payments places this provider in the 90th percentile of 39 transplant hepatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XifaxanRifaximin | 36 | $111,156 |
| VemlidyTenofovir Alafenamide | 30 | $49,061 |
| Entecavir | 54 | $13,406 |
| Ursodiol | 12 | $2,127 |
| Azathioprine | 17 | $706 |
| Mycophenolate Mofetil | 13 | $458 |
| Spironolactone | 22 | $337 |
| Carvedilol | 44 | $292 |
| Ciprofloxacin Hcl | 11 | $175 |
| Furosemide | 26 | $131 |
| Prednisone | 11 | $49 |
Paid to pharmacies, not to this prescriber.
Other transplant hepatology in San Francisco
- Kidist YimamSan Francisco$53K
- Bilal HameedSan Francisco$44K
- Jennifer PriceSan Francisco$11K
- Danielle BrandmanSan Francisco$7K
- Chanda HoSan Francisco$3K
- Edward HoltSan Francisco$3K
- Jin GeSan Francisco$2K
- Jennifer GuySan Francisco$245
- Raphael MerrimanSan Francisco$217
- Adil WakilSan Francisco$96
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.